Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


David Ridley

Senior Editor

Coventry, UK
David's coverage specializes in OTC medicines, dietary supplements and self-care medical devices. David is interested in regulatory gray areas such as the borderlines between medicines, supplements and medical devices, as well as botanical ingredients. David also regularly speaks to industry leaders and experts about the latest trends to deliver crucial market intelligence to HBW Insight readers, and co-hosts the Over the Counter podcast. In his spare time, David spends time in his allotment garden, reading/watching science fiction and worrying about climate change.

Latest From David Ridley

Over The Counter: Women’s Hormonal Wellness And The Power Of Herbs, With The SABI’s Hilary Metcalfe and Anna Cave-Bigley

In this episode of HBW Insight's Over the Counter podcast, we chat with women’s health start-up The SABI about the power of herbal medicine for hormonal wellness.

Europe Wellness

AESGP Meeting: Real World Evidence Could Drive Rx-To-OTC Switch, If Regulators Embrace It

Real-world data and evidence, for example generated by digital consumer health technology like apps and wearables, could provide crucial support for Rx-to-OTC switch applications, argues Sanofi Consumer Healthcare’s Penny Glover at the Association of the European Self-Care Industry's 60th Annual Meeting in Brussels, Belgium. Recent research by Sanofi indicates that regulators are actually already using RWD and RWE in many cases when assessing switch applications, even if they do not call it that. 

International Health

AESGP Annual Meeting: OTC Firms Must ‘Innovate Harder’ To Realize Growth Opportunity

Industry can look forward to a global OTC market compound annual growth rate of around 7% over the next few years, according to IQVIA Consumer Health. Innovation will be key to ensure individual companies realize this level of growth. IQVIA CH's Amit Shukla and Simon-Kucher & Partners' Clemens Oberhammer point to some key consumer trends to keep an eye on at the recent AESGP Annual Meeting in Brussels. 

International Health

AESGP Meeting: Climate Inaction Could Cost Healthcare Companies 10-20% Operating Profit

Failing to take sufficient action on climate change could be a costly business for consumer health companies. However, the good news from the AESGP's 60th Annual Meeting in Brussels, Belgium, is that at least half of the cost of decarbonizing will be balanced by savings, according to Boston Consulting Group. And climate change adaption will present firms with a wide variety of opportunities for product innovation, IQVIA Consumer Health's Volker Spitzer tells delegates.

International Health

AESGP Meeting: Medicine Packaging Exemption ‘Not Helpful’ For Circular Economy

Should the consumer health industry be exempt from the EU Packaging and Packaging Waste Directive? This question is hotly debated by representatives from major flexible packaging supplier Amcor and OTC manufacturer Perrigo at the 60th AESGP Annual Meeting in Brussels, Belgium. 

Europe Health

AESGP Meeting: Industry Must Be ‘Organized, Bold And Unapologetic’ About Value Of Self-Care

The Association of the European Self-Care Industry's 60th Annual Meeting in Brussels, Belgium, opens with a rousing call to action from president Jonathan Workman. Looking to the upcoming EU elections, Workman urges industry to push for widening access to OTC medicines through switch, digital and sustainable investment, improved health literacy and regulatory flexibility.

Europe Health
See All